Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1951 AL 1965

Integration of palliative care in Parkinson's disease management

Senderovich H, Jimenez Lopez B.

Curr Med Res Opin. 2021 Oct;37(10):1745-1759. doi: 10.1080/03007995.2021.1954895. Epub 2021 Jul 30.

Montreal Cognitive Assessment for the detection of dementia

Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S.

Cochrane Database Syst Rev. 2021 Jul 13;7(7):CD010775. doi: 10.1002/14651858.CD010775.pub3.

Post-COVID worsening of a Parkinson's disease patient

Boika AV, Sialitski MM, Chyzhyk VA, Ponomarev VV, Fomina EG.

Clin Case Rep. 2021 Jul 6;9(7):e04409. doi: 10.1002/ccr3.4409. eCollection 2021 Jul.

On the correlation between serum Cystatin C and Parkinson's disease in the Chinese population: a promising biomarker?

Yang CG, Cai SM, Liu CY, Chen C.

J Integr Neurosci. 2021 Jun 30;20(2):349-357. doi: 10.31083/j.jin2002034.

Potential protective role of astrocytes in the pathogenesis of astrocyte-mediated synaptic plasticity of Parkinson's disease

Zhang Y, Lu K.

J Integr Neurosci. 2021 Jun 30;20(2):515-525. doi: 10.31083/j.jin2002055.

The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database

Sato K, Mano T, Niimi Y, Iwata A, Toda T, Iwatsubo T.

Biosci Trends. 2021 Sep 22;15(4):219-230. doi: 10.5582/bst.2021.01194. Epub 2021 Jul 15.

Hypothalamic α-synuclein and its relation to autonomic symptoms and neuroendocrine abnormalities in Parkinson disease

De Pablo-Fernández E, Warner TT.

Handb Clin Neurol. 2021;182:223-233. doi: 10.1016/B978-0-12-819973-2.00015-0.

Lewy bodies in the olfactory system and the hypothalamus

Cersosimo MG, Benarroch EE, Raina GB.

Handb Clin Neurol. 2021;182:235-244. doi: 10.1016/B978-0-12-819973-2.00016-2.

Olfaction as an early marker of Parkinson's disease and Alzheimer's disease

Walker IM, Fullard ME, Morley JF, Duda JE.

Handb Clin Neurol. 2021;182:317-329. doi: 10.1016/B978-0-12-819973-2.00030-7.

Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease

Wong JH, Barron AM, Abdullah JM.

Front Pharmacol. 2021 Jun 29;12:687935. doi: 10.3389/fphar.2021.687935. eCollection 2021.

Novel N-Heteroaryl Quinazolin-2-amine Derivatives as LRRK2 Inhibitors for Treating Parkinson's Disease

Sabnis RW.

ACS Med Chem Lett. 2021 Jun 9;12(7):1063-1064. doi: 10.1021/acsmedchemlett.1c00295. eCollection 2021 Jul 8.

Atypical parkinsonism and self-mutilation: A new lens on the old concept

Salari M, Etemadifar M, Ghanbari K.

Clin Case Rep. 2021 Jul 9;9(7):e04432. doi: 10.1002/ccr3.4432. eCollection 2021 Jul.

Can COVID-19 accelerate neurodegeneration?

Salari M, Etemadifar M.

Clin Case Rep. 2021 Jul 9;9(7):e04433. doi: 10.1002/ccr3.4433. eCollection 2021 Jul.

Ropinirole-Associated Orthostatic Hypotension as Cause of a Prescribing Cascade in an Elderly Man

Becerra AF, Boch M, Al-Mezrakchi YA.

Cureus. 2021 Jun 7;13(6):e15506. doi: 10.7759/cureus.15506. eCollection 2021 Jun.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias